cancer detection

5+ articles

AI AI dependency AI healthcare AI in medicine AI investment

AI Dependency in Medicine: A Double-Edged Sword for Cancer Detection?

Doctors' reliance on AI technology in colonoscopies is linked to a decline in their independent cancer detection abilities. A recent study published in The Lancet highlights this conundrum, as it reveals the potential deskilling effects ensued from consistent AI support. The research shows a noteworthy 20% drop in doctors' detection rates without AI, raising questions about AI’s impact on diagnostic skills in critical healthcare procedures.

Aug 14

AI Dependency in Medicine: A Double-Edged Sword for Cancer Detection?

UK's £1 Billion AI Leap: Supercomputers & Healthcare Innovation

The UK's ambitious £1 billion investment focuses on escalating its AI computing infrastructure, with the goal of expanding public compute capacity twentyfold in five years. This initiative merges supercomputers into the AI Research Resource (AIRR) system and births National Supercomputing Centres. The funding primarily promotes AI R&D, notably in healthcare sectors like earlier cancer detection at University College London.

Jul 18

UK's £1 Billion AI Leap: Supercomputers & Healthcare Innovation

Craif Secures $22M to Revolutionize Early Cancer Detection with AI-Powered miRNA Tech

Japanese startup Craif is making waves as it secures $22 million in Series C funding to bring its groundbreaking AI-driven cancer detection platform to the U.S. market. Using microRNA (miRNA) from urine, Craif's miSignal test offers a non-invasive alternative to traditional methods, aiming to detect seven types of cancer early on. With plans to expand detection capabilities and explore other applications, this innovative platform is on track for U.S. trials by 2029, with FDA approval on the horizon.

Apr 28

Craif Secures $22M to Revolutionize Early Cancer Detection with AI-Powered miRNA Tech

Alibaba's Damo Academy Achieves FDA Breakthrough with AI Cancer Tool

Alibaba's Damo Academy has secured FDA 'breakthrough device' status for its AI-driven pancreatic cancer detection tool, Damo Panda, accelerating its approval process in the US. This deep learning marvel enhances early-stage cancer detection with greater sensitivity than traditional methods, bringing hope to many.

Apr 22

Alibaba's Damo Academy Achieves FDA Breakthrough with AI Cancer Tool

AI Outshines Humans in Ovarian Cancer Detection: Revolutionary Study Shows Promising Results

A groundbreaking study published in Nature Medicine reveals an AI model that detects ovarian cancer from ultrasound images with an impressive 86% accuracy, outperforming human specialists. Trained on over 17,000 images from eight countries, this AI system is making waves in the medical community, though experts urge for further validation before clinical implementation.

Jan 6

AI Outshines Humans in Ovarian Cancer Detection: Revolutionary Study Shows Promising Results